Retour
Fourchette du Jour
114,62 €
117,33 €
Fourchette 52 Semaines
114,36 €
172,23 €
Volume
2 631 985
Moyenne 50J / 200J
124,41 €
/
138,35 €
Clôture Précédente
115,67 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,0 | 0,4 |
| P/B | 15,2 | 2,9 |
| ROE % | 66,0 | 3,7 |
| Net Margin % | 28,2 | 3,8 |
| Rev Growth 5Y % | 5,0 | 10,0 |
| D/E | 2,9 | 0,2 |
Points Clés
Revenue grew 5,04% annually over 5 years — modest growth
ROE of 65,99% indicates high profitability
Net margin of 28,23% shows strong profitability
Debt/Equity of 2,85 — high leverage
Generating 2,28B in free cash flow
Cash machine — converts 85,41% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
5,04%
Revenue (1Y)2,28%
Earnings (1Y)7,52%
FCF Growth (3Y)18,68%
Qualité
Return on Equity
65,99%
ROIC21,04%
Net Margin28,23%
Op. Margin38,00%
Sécurité
Debt / Equity
2,85
Current Ratio3,03
Interest Coverage14,80
Valorisation
P/E Ratio
19,00
P/B Ratio15,24
EV/EBITDA16,11
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,28% | Revenue Growth (3Y) | 5,26% |
| Earnings Growth (1Y) | 7,52% | Earnings Growth (3Y) | 6,79% |
| Revenue Growth (5Y) | 5,04% | Earnings Growth (5Y) | 7,03% |
| Profitability | |||
| Revenue (TTM) | 9,47B | Net Income (TTM) | 2,67B |
| ROE | 65,99% | ROA | 17,28% |
| Gross Margin | 70,49% | Operating Margin | 38,00% |
| Net Margin | 28,23% | Free Cash Flow (TTM) | 2,28B |
| ROIC | 21,04% | FCF Growth (3Y) | 18,68% |
| Safety | |||
| Debt / Equity | 2,85 | Current Ratio | 3,03 |
| Interest Coverage | 14,80 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 19,00 | P/B Ratio | 15,24 |
| P/S Ratio | 5,36 | PEG Ratio | 2,04 |
| EV/EBITDA | 16,11 | Dividend Yield | 0,02% |
| Market Cap | 50,78B | Enterprise Value | 57,96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9,47B | 9,26B | 8,54B | 8,08B | 7,78B |
| Net Income | 2,67B | 2,49B | 2,34B | 2,11B | 2,04B |
| EPS (Diluted) | 6,02 | 5,47 | 5,07 | 4,49 | 4,27 |
| Gross Profit | 6,67B | 6,40B | 5,83B | 5,48B | 5,31B |
| Operating Income | 3,60B | 3,39B | 3,07B | 2,93B | 2,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 15,47B | 14,24B | 14,29B | 14,93B | 13,90B |
| Total Liabilities | 12,14B | 9,47B | 9,30B | 10,52B | 9,36B |
| Shareholders' Equity | 3,33B | 4,77B | 5,00B | 4,41B | 4,54B |
| Total Debt | 9,49B | 6,74B | 6,76B | 8,09B | 6,74B |
| Cash & Equivalents | 2,31B | 1,99B | 2,04B | 3,58B | 3,48B |
| Current Assets | 6,77B | 5,99B | 6,34B | 7,51B | 6,93B |
| Current Liabilities | 2,24B | 3,41B | 1,89B | 3,17B | 1,80B |